期刊文献+

甲状旁腺激素及其拟似剂治疗骨质疏松症的研究进展 被引量:13

Progress in treatment of osteoporosis by parathyroid hormone and its analogs
暂未订购
导出
摘要 甲状旁腺激素(PTH)目前已作为一种促骨合成药物,用于骨质疏松症的临床治疗。它所发挥的生物学效应取决于其作用模式和剂量,即间断小剂量使用能增加骨形成,而大剂量持续使用则加速骨吸收使骨量减少。PTH对骨代谢调节的确切机制尚未阐明,大量研究工作力图从各个层面寻找PTH治疗骨质疏松的效应模式及机制,以便使其更安全有效地应用于临床,本文对目前的研究进展作综述。 Parathyroid hormone (PTH) and its analogs have been used as bone anabolic agents for the treament of severe osteoporosis in clinic. PTH exerts biphasic effects on osteoblastie cells, depending on dose, duration of exposure. The anabolic actions of PTH are dependent on an intermittent regimen. On the contrary, continuous administration will result in bone loss through the increase in resorption. Its mechanisms of action on bone cells are unclear. This article reviews the progress in the researches on the effect of PTH and its analogs on osteoporosis.
作者 苏欣 廖二元
出处 《国际内科学杂志》 CAS 2007年第11期645-648,共4页 International Journal of Internal Medicine
关键词 甲状旁腺激素 骨形成 骨吸收 骨质疏松症 Parathyroid hormone Bone formation Bone resorption Osteoporosis
  • 相关文献

参考文献22

  • 1Divieti P, Inomata N, Chapin K, et al. Receptors liar the carboxyl-terminal region of PTH (1-84) are highly expressed in osteocytic cells. Endocrinology, 2001 , 142 (4) :916-925.
  • 2Nguyen-Yamamoto L, Rousseau L, Brossard JH, et al. Synthetic earhoxvl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from tile PTH/PTH-related peptide receptor. Endocrinology, 2001 , 142 ( 4 ) : 1386- 1392.
  • 3Juppner H, John, T, Potts JT Jr. Immunoassays for the detection of parathyroid hormone. J Bone Mirror Res, 2002, 17 (suppt 2) :N81-N86.
  • 4Shimizu M, Carter PH, Khatri A, et al. Enhanced activity in parathyroid hormone (1-14) and ( 1-11 ) : novel peptides probing ligand-receptor interactions. Endocrinology, 2001, 142 ( 7 ) :3068-3074.
  • 5Dempster DW, Hughes-Begos CE, Plavetie-Chee K, et al. Normal human osleoclasts formed fronl peripheral blood monoeytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts. J Cell Biochem, 2005, 95( 1 ) :139-148
  • 6Fox J, Miller MA, Newman MK, el al. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and eorlieal bone strength. Calcif Tissue Int, 2006, 79(4) :262-272.
  • 7Stephan S, van de Flierdt J, Loumi S, et al. Intermittent administration of the circulating form of human parathyroid hormone (hPTH-1-37) prevents bone loss in ovariectomized rats, Eur J Med Res, 2007,12(1):13-20.
  • 8Iida-Klein A, Lu SS, Cosman F, et al. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity. Bone, 2007,40 (2) :391-398,
  • 9Davies J, Chambers TJ. Parathyroid hormone activates adhesion in bone marrow stromal precursor cells. J Endocrinol, 2004,180(4) :505-513.
  • 10Wang YH, Liu Y, Buhl K, et al. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res, 2005,20( 1 ) :5-14.

同被引文献120

引证文献13

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部